UNCY |
Unicycive Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
9.99% |
$6.08M |
|
11.5M |
|
Great Point Partners, LLC |
Dec 31, 2024 |
PMN |
ProMIS Neurosciences Inc. |
Common Shares, no par value per share |
9.99% |
$2.1M |
|
3.33M |
0% |
Great Point Partners, LLC |
Jun 30, 2025 |
|
Inventiva S.A. |
Ordinary shares, nominal value 0.01 Euro per share |
7.42% |
|
|
10.6M |
|
Great Point Partners, LLC |
May 5, 2025 |
VTGN |
Vistagen Therapeutics, Inc. |
Common Stock, $0.001 par value per share |
6.59% |
$6.52M |
|
2.06M |
0% |
Great Point Partners, LLC |
Jun 30, 2025 |
UNCY |
Unicycive Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
6.24% |
$3.39M |
|
797K |
|
Great Point Partners, LLC |
Jun 30, 2025 |
CNTX |
Context Therapeutics Inc. |
Common Stock |
5.22% |
$4.07M |
|
4.68M |
0% |
Great Point Partners, LLC |
Jun 30, 2025 |
ZURA |
Zura Bio Ltd |
Class A Ordinary Shares |
5.12% |
$3.55M |
|
3.17M |
0% |
Great Point Partners, LLC |
May 8, 2025 |
OTLK |
Outlook Therapeutics, Inc. |
Common Stock, $0.001 par value per share |
4.99% |
$2.42M |
|
2.22M |
0% |
Great Point Partners, LLC |
Jun 30, 2025 |
OPTN |
OPTINOSE, INC. |
Common Stock, $0.001 par value per share |
4.94% |
$4.74M |
-$3.33M |
526K |
-41.3% |
Great Point Partners, LLC |
Mar 31, 2025 |
NGNE |
NEUROGENE INC. |
Common Stock, par value $0.000001 per share |
2.98% |
$4.87M |
|
443K |
|
Great Point Partners, LLC |
Dec 31, 2024 |